Trial of Enzastaurin and Bevacizumab in Participants With Recurrent Malignant Gliomas

Clinical trial NCT00586508 · COMPLETED

Trial details

NCT number: NCT00586508
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Glioblastoma

Start date: 2007-11-01
Primary completion: 2013-10-01
Enrollment: 81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.